View in EDS

Convalescent plasma in patients receiving rituximab or ocrelizumab for multiple sclerosis or neuromyelitis Optica spectrum disorder with Covid-19: A multicenter retrospective study.

Saved in:
Bibliographic Details
Title: Convalescent plasma in patients receiving rituximab or ocrelizumab for multiple sclerosis or neuromyelitis Optica spectrum disorder with Covid-19: A multicenter retrospective study.
Authors: Dequidt, Tanguy1 (AUTHOR) tanguy.dequidt@gmail.com, Richier, Quentin2 (AUTHOR), Louapre, Céline3 (AUTHOR), Ader, Florence4 (AUTHOR), Merad, Yanis4 (AUTHOR), Lauwerier, Nicolas5 (AUTHOR), Jacomet, Christine6 (AUTHOR), Carles, Michel7 (AUTHOR), Biron, Charlotte8 (AUTHOR), Gendrin, Vincent9 (AUTHOR), Marlat, Clément10 (AUTHOR), Danion, François11 (AUTHOR), Lepage, Tristan M12 (AUTHOR), Sotto, Albert13 (AUTHOR), Bourdellon, Loïc14 (AUTHOR), Mania, Alexandre15 (AUTHOR), Martinot, Martin16 (AUTHOR), Falher, Georges Le17 (AUTHOR), Ferre, Alexis18 (AUTHOR), Pilmis, Benoit19 (AUTHOR)
Source: International Journal of Infectious Diseases. Feb2025, Vol. 151, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Description
ISSN:12019712
DOI:10.1016/j.ijid.2024.107323